Thursday, July 21, 2016
Wednesday, June 29, 2016
Successful Trial of Zika vaccine in mice using ADI's Zika Env ELISA kits
Alpha Diagnostic International's (ADI) Mouse ZIKV Env ELISA
kits were used in the peer reviewed paper published yesterday in the journal Nature.
The authors demonstrate that two different ZIKV vaccine candidates provided
complete protection in mice against a ZIKV strain from Brazil and suggest that
a ZIKV vaccine for humans will likely be feasible. The rapid development of a
safe and effective vaccine to prevent the Zika virus (ZIKV) is a global
priority, as infection in pregnant women has been shown to lead to fetal
microcephaly and other major birth defects. Science Daily news release reported that
vaccine protection against Zika has been achieved- https://www.sciencedaily.com/releases/2016/06/160628114836.htm
The neutralizing antibodies that provided immunity to Zika
infection were assessed using ADI’s ZIKV Env ELISA kits. http://www.nature.com/nature/journal/vaap/ncurrent/pdf/nature18952.pdf
ADI's mission is to develop and supply diagnostic and
validating solutions for promoting global health through improved vaccine
therapeutics and mitigating the spread of human and animal diseases.
ADI has remained faithful to its mission by being the first
company to develop ELISA kits during the Ebola virus epidemic in Africa as well
as the Zika virus episodes in Brazil and the Americas. ADI has developed
multiple Zika virus antibody (IgM and IgG) ELISA kits for humans, mice and
monkeys which are currently being used for zika virus detection and vaccine
development. It is worth recalling that ZIKV is a member of the flavivirus
family of viruses which are transmitted by mosquitoes, and ZIKV is responsible
for an unprecedented epidemic in the Americas.
Please visit the link for ADI Zika products which include
ELISA kits, antibodies and recombinant proteins-
ADI supports research, diagnostic and vaccine development
for diseases diagnostics, surveillance and prevention.
Friday, May 20, 2016
ADI's TruStrip Meat Adulteration Rapid Test to the Rescue
Fortunately, a simple solution is at hand. ADI has been marketing several kits for rapidly testing for the presence of meats or foreign meats where they shouldn't be present. The test kits are very simple (similar to home pregnance test kits) and can be used by anyone without any need for special skills. More details about the TruStrip RDT Meat Adulteration Tests can be found here
Tuesday, May 10, 2016
ADI to Exhibit at the 14th Annual Vaccines + Therapeutics Summit in Washington, DC, May 17-19, 2016
ADI will be attending and exhibiting at the 14th Annual Vaccines + Therapeutics Summit in Washington, DC on May 17-19. In the fight against emerging infectious diseases, ADI is making available validating and research tools for the scientific and medical communities.
ADI has developed Zika antibody ELISA tests as well as polyclonal and monoclonal antibodies to some Zika proteins (Env, NS1, prM, and Capsid). For additional details about these products, please follow the link below.
ADI has also developed an exciting product called TruStrip Sample Transfer System (STS) that makes it very easy to collect biological samples on the strips, dry at room temp, store or send by regular mail without incurring huge expenses for cold/frozen chain or custom regulations. For further details about TruStrip STS, please follow the link below.
http://www.4adi.com/objects/catalog/product/extras/TruStrip-STS-Sample-Transfer-System-Flr.pdf
A video that describes the TruStrip STS product and applications can be viewed at the link below.
https://www.youtube.com/watch?v=FZB7L4zrwFM
https://www.youtube.com/watch?v=FZB7L4zrwFM
For addition details about the summit, please follow the link below.
http://www.infocastinc.com/events/vaccines-therapeutics
http://www.infocastinc.com/events/vaccines-therapeutics
Saturday, April 2, 2016
ADI to Participate in the International Zika Summit 2016
An International Zika Summit has been organized to bring together scientists and public health professionals around the world working on Zika. The speed and extent of this outbreak, which the WHO declared a Public Health Emergency of International Concern, requires open collaborations between researchers, the public health community and the public. This meeting will provide a venue for open such discussions. ADI will be participating in this summit and present the availability of kits and reagents that the research community could use for developing countermeasures against the spread of this disease. For further details about the summit, please visit http://www.zikasummit2016.org/
Zika Virus Detection in Humans and Animals Using ELISA Kits
San Antonio, Texas-based biotech company Alpha Diagnostic International, Inc (ADI) has developed several ELISA test kits for the detection of major Zika viral protein antibodies (Capsid, Envelope, prM, and NS1). The ELISA kits are available for humans as well as monkeys and mice that can be readily used in ongoing research and vaccine development projects on animal models of disease. Read the entire press release at http://www.prweb.com/releases/2016/03/prweb13244687.htm
Wednesday, March 30, 2016
ADI participates in NIH-NIAID sponsored meeting on Zika virus
The Zika virus epidemic that originated in other parts of the world has now made its way into US and has become a critically important research area for development of diagnostics, vaccines and therapeutics. As a new disease that shows all the signs of becoming a global epidemic, there is an urgent need for reagents and tools that are necessary for developing methods to combat this disease. The first Zika Virus conference (Zika Virus in the Americas: An HHS Expert Consultation to Accelerate the Development of Countermeasures) was recently concluded at North Bethesda in Maryland (Mar 28 - 29, 2016). At this conference, Dr. Masarrat Ali had an opportunity to interact with several members of the research community to discuss and present reagents that are immediately available from ADI and understand other needs of the community in order to develop countermeasures in a timely manner. ADI is the first company to develop reagents designed to help researchers across the world who are engaged in Zika virus research. For additional details on these reagents, please visit http://4adi.com/commerce/catalog/srhkeyword.cz
Subscribe to:
Posts (Atom)